{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:50:30Z","timestamp":1788022230742,"version":"build-2784847793"},"reference-count":25,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,10,15]]},"published-print":{"date-parts":[[2026,1]]},"DOI":"10.2967\/jnumed.125.270650","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T16:10:16Z","timestamp":1763050216000},"page":"79-84","source":"Crossref","is-referenced-by-count":2,"title":["Prospective Histopathologic Comparison Between [\n                    <sup>18<\/sup>\n                    F]PSMA-1007 PET\/CT and [\n                    <sup>18<\/sup>\n                    F]Fluciclovine PET\/CT of Intraprostatic Tumor Detection: The TRACER Study"],"prefix":"10.2967","volume":"67","author":[{"given":"Robert J.","family":"Hoekstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Beulens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Roef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Nederend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi V.N.","family":"K\u00fcsters-Vandevelde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrie P.","family":"Beerlage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik J.H.","family":"Baas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik M.","family":"Somford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Sedelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul A.","family":"van Basten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendricus J.E.J.","family":"Vrijhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"2026010206300914000_67.1.79.1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.euo.2020.12.004","article-title":"Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: a systematic review and meta-analysis","volume":"4","author":"Mazzone","year":"2021","journal-title":"Eur Urol Oncol."},{"key":"2026010206300914000_67.1.79.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.07.029"},{"key":"2026010206300914000_67.1.79.3","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263448"},{"key":"2026010206300914000_67.1.79.4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.euo.2023.04.006","article-title":"Head-to-head comparison of 18F- PSMA-1007 positron emission tomography\/computed tomography and multiparametric magnetic resonance imaging with whole-mount histopathology as reference in localisation and staging of primary prostate cancer","volume":"6","author":"Exterkate","year":"2023","journal-title":"Eur Urol Oncol."},{"key":"2026010206300914000_67.1.79.5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00259-017-3875-1","article-title":"Prospective evaluation of 18F FACBC PET\/CT and PET\/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial)","volume":"45","author":"Jambor","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026010206300914000_67.1.79.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262398"},{"key":"2026010206300914000_67.1.79.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.257238"},{"key":"2026010206300914000_67.1.79.8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.eururo.2021.03.017","article-title":"Prostate-specific membrane antigen and fluciclovine transporter genes are associated with variable clinical features and molecular subtypes of primary prostate cancer","volume":"79","author":"Chu","year":"2021","journal-title":"Eur Urol."},{"key":"2026010206300914000_67.1.79.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.204032"},{"key":"2026010206300914000_67.1.79.10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.831429"},{"key":"2026010206300914000_67.1.79.11","doi-asserted-by":"crossref","first-page":"e586s","DOI":"10.6061\/clinics\/2018\/e586s","article-title":"Clinical perspectives of PSMA PET\/MRI for prostate cancer","volume":"73","author":"Barbosa","year":"2018","journal-title":"Clinics (Sao Paulo)."},{"key":"2026010206300914000_67.1.79.12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3892\/mco.2012.54","article-title":"L-type amino acid transporter 1 expression is highly correlated with Gleason score in prostate cancer","volume":"1","author":"Segawa","year":"2013","journal-title":"Mol Clin Oncol."},{"key":"2026010206300914000_67.1.79.13","first-page":"187","article-title":"Progress in applications of 18F-fluciclovine in diagnosis of prostate cancer","volume":"45","author":"Wang","year":"2020","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban."},{"key":"2026010206300914000_67.1.79.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.143628"},{"key":"2026010206300914000_67.1.79.15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ERUS-SIOG guidelines on prostate cancer\u20142024 update. Part I: screening, ciagnosis and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol."},{"key":"2026010206300914000_67.1.79.16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.eururo.2023.06.008","article-title":"Prostate-specific membrane antigen reporting and data system version 2.0","volume":"84","author":"Werner","year":"2023","journal-title":"Eur Urol."},{"key":"2026010206300914000_67.1.79.17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00259-019-04614-y","article-title":"[18F]fluciclovine PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging\u2013version 1.0","volume":"47","author":"Nanni","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026010206300914000_67.1.79.18","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jamaoncol.2024.3196","article-title":"Fluorine-18 prostate-specific membrane antigen-1007 PET\/CT vs multiparametric MRI for locoregional staging of prostate cancer","volume":"10","author":"Mookerji","year":"2024","journal-title":"JAMA Oncol."},{"key":"2026010206300914000_67.1.79.19","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyv181"},{"key":"2026010206300914000_67.1.79.20","doi-asserted-by":"crossref","first-page":"e210091","DOI":"10.1148\/rycan.210091","article-title":"18F-fluciclovine versus PSMA PET imaging in primary tumor detection during initial staging of high-risk prostate cancer: a systematic review and meta-analysis","volume":"4","author":"Yadav","year":"2022","journal-title":"Radiol Imaging Cancer."},{"key":"2026010206300914000_67.1.79.21","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.euo.2024.01.002","article-title":"Fluorine-18-labelled prostate-specific membrane antigen positron emission tomography\/computed tomography of magnetic resonance imaging to diagnose and localise prostate cancer. A prospective single-arm paired comparison (PEDAL)","volume":"7","author":"Wong","year":"2024","journal-title":"Eur Urol Oncol."},{"key":"2026010206300914000_67.1.79.22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s43018-023-00539-6","article-title":"Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer","volume":"4","author":"Bakht","year":"2023","journal-title":"Nat Cancer."},{"key":"2026010206300914000_67.1.79.23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.euo.2020.06.012","article-title":"A prospective comparison of 18F-prostate-specific membrane antigen-1007 positron emission tomography computed tomography, whole-body 1.5 T magnetic resonance imaging with diffusion-weighted imaging, and single-photon emission computed tomography\/computed tomography with traditional imaging in primary distant metastasis staging of prostate cancer (PROSTAGE)","volume":"4","author":"Anttinen","year":"2021","journal-title":"Eur Urol Oncol."},{"key":"2026010206300914000_67.1.79.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.267260"},{"key":"2026010206300914000_67.1.79.25","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30415-2"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.270650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T14:31:16Z","timestamp":1767364276000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.270650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,2]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.2967\/jnumed.125.270650"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.270650","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}